CEO Seunghoon Choi Increases Stake to 1% via Open Market Purchase, Signaling Management Confidence


  • CEO Seunghoon Choi acquired 4,027 common shares on June 1, 2026 via open market purchase at 6,700 won, increasing his stake from 0.89% to 1.00% (up 0.11%p).
  • The purchase price slightly above the current market price (6,640 won) suggests management's perception of undervaluation and confidence in future growth.
  • Although the small buy size limits direct price impact, insider buying is generally viewed as a positive signal.
  • [AI Summary]CEO Choi's small open market purchase raised his stake to 1%, and the premium to the current price reflects management confidence, but the minimal scale limits the impact on shareholder value; investors should monitor further stake changes and earnings momentum.

KOSDAQ Filing Information


  • Filing: Report on Ownership of Specific Securities by Executives and Major Shareholders
  • Company: Daesung Microbiological Labs (036480)
  • Submission: Seunghoon Choi
  • Receipt: 06-01-2026